Intriguingly, the proinflammatory cytokine IL-23 has been identified as a stimulant for CDK7 expression in CD4+ T cells, further amplifying glycolytic activity through activation of the PKB/mTOR/HIF-1α signaling network in a psoriasis-like mouse model induced by imiquimod (IMQ) (19). Here, IL23A is linked to psoriasis.